[go: up one dir, main page]

WO2004110323A1 - Dressing - Google Patents

Dressing Download PDF

Info

Publication number
WO2004110323A1
WO2004110323A1 PCT/DE2003/001786 DE0301786W WO2004110323A1 WO 2004110323 A1 WO2004110323 A1 WO 2004110323A1 DE 0301786 W DE0301786 W DE 0301786W WO 2004110323 A1 WO2004110323 A1 WO 2004110323A1
Authority
WO
WIPO (PCT)
Prior art keywords
opacity
value
contact layer
dimensioned
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2003/001786
Other languages
German (de)
French (fr)
Inventor
Beatrice Pfister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP03817241A priority Critical patent/EP1680058A1/en
Priority to PCT/DE2003/001786 priority patent/WO2004110323A1/en
Publication of WO2004110323A1 publication Critical patent/WO2004110323A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00153—Wound bandages coloured or with decoration pattern or printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00285—Wound bandages medication confinement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00387—Plasters use skin protection
    • A61F2013/00391—Plasters use skin protection from irradiation, e.g. sun
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00544—Plasters form or structure
    • A61F2013/00646—Medication patches, e.g. transcutaneous
    • A61F2013/00651—Medication patches, e.g. transcutaneous tapered, bevelled or chamfered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A61L2300/222—Steroids, e.g. corticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Definitions

  • the invention relates to a plaster device for covering selected areas of the human skin, with a carrier layer having a surface and a
  • a contact layer is provided, the underside of which comes into contact with a selected skin site.
  • Plaster devices of the type mentioned above are used in the prior art, on the one hand to protect damaged areas of skin from mechanical effects from the outside and thereby promote a healing process.
  • the known devices are used to bring epidermis permeable medically active substances into skin contact, so as to have a longer duration Period to ensure uniform delivery of the substances into the human body.
  • the known plaster devices have the disadvantage that in the case of the former application, in particular in the area of exposed body parts effective protection against curative UV radiation of the sun is not guaranteed, and that in the case of the latter application the substances to be introduced into the human body not are safely protected from degradation caused by UV radiation of the sun and / or accelerated decomposition in the form of decomposition or oxidation.
  • the object of the invention is therefore to provide a plaster device in which an effective protection against UV radiation of the sun is already guaranteed in the area of the surface of the carrier layer.
  • the protective layer has an opacity with a value greater than 0.55.
  • the protective layer has an opacity with a value greater than 0.55 achieves a device in which, on the one hand, in the area of exposed parts of the body effective protection against UV radiation which inhibits healing of the body Sun, and on the other hand, in the case where the patch device is provided for administering medically effective substances, the substances to be introduced into the human body are certainly provided a decomposition induced by UV radiation of the sun and / or accelerated decomposition in the form of decomposition or oxidation are protected.
  • opacity of 1 ie non-transparency for light of any wavelength, is not sought for the reason, because this can be achieved technically only with a simultaneous gas impermeability, which is not desirable from a medical point of view.
  • the opacity is defined here as that of a transparency inverse value between 0 and 1, where an opacity of 0 corresponds to 100 percent transparency and an opacity of 1 corresponds to 100 percent intransparency or complete absorption or reflection of light and UV rays.
  • the value of the opacity is dimensioned in the range between 0.6 and 0.9.
  • the value of the opacity depending on the application, is between 0.65 and 0.85, between 0.65 and 0.8, between 0.7 and 0.85 or between 0.75 and 0.9.
  • the respective opacity is preferably generated by a corresponding shading of the color brown.
  • the contact layer is formed by fiber parts of the hemp shrub.
  • the contact layer may alternatively be made of a conventional material such as wool or fleece and thereby be interspersed only with certain fiber parts of hemp shrubs and thus contain only a certain proportion, the fiber parts always always from the leaves or the Stems of hemp shrub may be formed.
  • Hemp fibers or hemp components generally have the advantage of an anti-inflammatory and healing-promoting effect of the contact layer.
  • the contact layer is designed to be hydrophilic for a first application for covering areas of skin in order to absorb bodily fluid escaping from an injured skin area.
  • the contact layer is preferably provided as a reservoir for epidermis-permeable medically active substances to be delivered to intended skin sites.
  • the reservoir contains, for example, a nicotine substitute, insulin, an asthma-effective cortisone or a substance that controls the vegetative nervous system for the control of travel diseases.
  • Fig. 1 shows a first preferred embodiment of the device according to the invention in a view from above;
  • FIG. 2 shows the preferred embodiment of the device according to the invention shown in FIG. 1 in a cross-sectional view
  • FIG. Fig. 3 shows another preferred embodiment of the device according to the invention in a view from above;
  • Fig. 5 shows a further preferred embodiment of the device according to the invention in a view from above.
  • Fig. 6 shows a further preferred embodiment of the device according to the invention in a view from above.
  • the plaster devices 100 according to the invention for covering selected areas of the human skin shown in FIGS. 1 to 6 comprise a carrier layer 110 having a surface 111 and a bottom surface 112, the surface 111 being provided with a protective layer, and being at least partially in the region of Bottom surface 112, a contact layer 120 is provided, the underside of which contacts a selected skin site.
  • the protective layer has an essential to the invention an opacity with a value greater than 0.55. In the embodiments shown in the figures, the value of the opacity is in the range between 0.6 and 0.9, the respective opacity being produced by a corresponding shade of the color brown.
  • the contact layer 120 of the illustrated invention is the contact layer 120 of the illustrated invention.
  • Plaster devices 100 are formed entirely of fiber parts of the hemp shrub, the fiber parts of which
  • the contact layer 120 is hydrophilically absorbent to absorb bodily fluids leaking from injured skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a dressing (100) for covering selected locations of the human skin, comprising a backing layer (110) with an upper surface (111) and with a lower surface (112), whereby the upper surface (111) is provided with a protective layer, and a contact layer (120) is provided, at least in part, in the area of the lower surface (112). The underside of this contact layer comes into contact with a selected skin location. The invention provides an effective protection from UV radiation of the sun already in the area of the upper surface (111) of the backing layer (110) by virtue of the fact that the protective layer has an opacity with a value greater than 0.55.

Description

PFLASTER-VORRICHTUNG PLASTER DEVICE

Die Erfindung betrifft eine Pflaster-Vorrichtung zum Abdecken ausgewählter Stellen der menschlichen Haut, mit einer Trägerschicht mit einer Oberfläche und einerThe invention relates to a plaster device for covering selected areas of the human skin, with a carrier layer having a surface and a

Unterfläche, wobei die Oberfläche mit einer Schutzschicht versehen ist, und mindestens teilweise im Bereich derUnder surface, wherein the surface is provided with a protective layer, and at least partially in the region of

Unterfläche eine Kontaktschicht vorgesehen ist, deren Unterseite mit einer ausgewählten Hautstelle in Kontakt tritt.Below a contact layer is provided, the underside of which comes into contact with a selected skin site.

Pflaster-Vorrichtungen der eingangs genannten Art werden im Stand der Technik einerseits verwendet, um lädierte Hautpartien vor mechanischen Einwirkungen von außen zu schützen und dadurch einen Heilungsprozess zu fördern. Zum anderen werden die bekannten Vorrichtungen verwendet, um epidermispermeable medizinisch wirksame Substanzen in Hautkontakt zu bringen, um so eine über einen längeren Zeitraum gleichmäßige Abgabe der Substanzen in den menschlichen Körper sicherzustellen. Die bekannten Pflaster-Vorrichtungen weisen jedoch den Nachteil auf, dass im Falle der ersteren Anwendung insbesondere im Bereich exponierter Körperteile ein effektiver Schutz vor heilungshemmender UV-Strahlung der Sonne nicht gewährleistet ist, und dass im Falle letzterer Anwendung die in den menschlichen Körper einzutragenden Substanzen nicht sicher vor einer durch UV-Strahlung der Sonne herbeigeführten und/oder beschleunigten Zersetzung in Form von Dekomposition oder Oxidation geschützt sind.Plaster devices of the type mentioned above are used in the prior art, on the one hand to protect damaged areas of skin from mechanical effects from the outside and thereby promote a healing process. On the other hand, the known devices are used to bring epidermis permeable medically active substances into skin contact, so as to have a longer duration Period to ensure uniform delivery of the substances into the human body. However, the known plaster devices have the disadvantage that in the case of the former application, in particular in the area of exposed body parts effective protection against curative UV radiation of the sun is not guaranteed, and that in the case of the latter application the substances to be introduced into the human body not are safely protected from degradation caused by UV radiation of the sun and / or accelerated decomposition in the form of decomposition or oxidation.

Aufgabe der Erfindung ist es deshalb, eine Pflaster- Vorrichtung zu schaffen, bei der schon im Bereich der Oberfläche der Trägerschicht ein effektiver Schutz vor UV- Strahlung der Sonne gewährleistet ist.The object of the invention is therefore to provide a plaster device in which an effective protection against UV radiation of the sun is already guaranteed in the area of the surface of the carrier layer.

Für eine Pflaster-Vorrichtung der eingangs genannten Art wird diese Aufgabe dadurch gelöst, dass die Schutzschicht eine Opazität mit einem Wert größer 0,55 aufweist.For a plaster device of the type mentioned above, this object is achieved in that the protective layer has an opacity with a value greater than 0.55.

Bevorzugte Ausführungsformen der Erfindung sind Gegenstand der Unteransprüche.Preferred embodiments of the invention are subject of the dependent claims.

Bei der erfindungsgemäßen Pflaster-Vorrichtung wird durch das Merkmal, dass die Schutzschicht eine Opazität mit einem Wert größer 0,55 aufweist, erreicht, dass eine Vorrichtung geschaffen ist, bei der zum einen im Bereich exponierter Körperteile ein effektiver Schutz vor heilungshemmender UV- Strahlung der Sonne gegeben ist, und bei der zum anderen in dem Fall, dass die Pflaster-Vorrichtung zum Verabreichen medizinisch wirksamer Substanzen vorgesehen ist die in den menschlichen Körper einzutragenden Substanzen sicher vor einer durch UV-Strahlung der Sonne herbeigeführten und/oder beschleunigten Zersetzung in Form von Dekomposition oder Oxidation geschützt sind. Eine Opazität von 1, d.h. Intransparenz für Licht jeglicher Wellenlänge, wird dabei aus dem Grunde nicht angestrebt, weil dies technisch nur mit einer gleichzeitigen Gas-Impermeabilität zu erreichen ist, die jedoch aus medizinischer Sicht nicht erwünscht ist. Die Opazität ist dabei als der einer Transparenz inverse Wert zwischen 0 und 1 definiert, wobei eine Opazität von 0 einer hundertprozentigen Transparenz und eine Opazität von 1 einer hundertprozentigen Intransparenz bzw. vollständigen Absorption oder Reflexion von Licht- und UV-Strahlen entspricht.In the case of the plaster device according to the invention, the feature that the protective layer has an opacity with a value greater than 0.55 achieves a device in which, on the one hand, in the area of exposed parts of the body effective protection against UV radiation which inhibits healing of the body Sun, and on the other hand, in the case where the patch device is provided for administering medically effective substances, the substances to be introduced into the human body are certainly provided a decomposition induced by UV radiation of the sun and / or accelerated decomposition in the form of decomposition or oxidation are protected. An opacity of 1, ie non-transparency for light of any wavelength, is not sought for the reason, because this can be achieved technically only with a simultaneous gas impermeability, which is not desirable from a medical point of view. The opacity is defined here as that of a transparency inverse value between 0 and 1, where an opacity of 0 corresponds to 100 percent transparency and an opacity of 1 corresponds to 100 percent intransparency or complete absorption or reflection of light and UV rays.

Gemäß einer ersten bevorzugten Ausführungsform der erfindungsgemäßen Vorrichtung ist deshalb vorgesehen, dass der Wert der Opazität im Bereich zwischen 0,6 und 0,9 bemessen ist. Gemäß besonderer Ausführungsformen ist der Wert der Opazität je nach Anwendungsfall auf zwischen 0,65 und 0,85, zwischen 0,65 und 0,8, zwischen 0,7 und 0,85 oder auf zwischen 0,75 und 0,9 bemessen. Die jeweilige Opazität ist dabei vorzugsweise durch eine entsprechende Schattierung der Farbe Braun erzeugt.According to a first preferred embodiment of the device according to the invention, it is therefore provided that the value of the opacity is dimensioned in the range between 0.6 and 0.9. According to particular embodiments, the value of the opacity, depending on the application, is between 0.65 and 0.85, between 0.65 and 0.8, between 0.7 and 0.85 or between 0.75 and 0.9. The respective opacity is preferably generated by a corresponding shading of the color brown.

Gemäß einer anderen bevorzugten Ausführungsform der erfindungsgemäßen Vorrichtung ist vorgesehen, dass die Kontaktschicht von Faserteilen des HanfStrauches gebildet ist. Die Kontaktschicht kann alternativ auch einem herkömmlichen Material wie etwa Wolle oder Flies hergestellt sein und dabei lediglich mit bestimmten Faserteilen des HanfStrauches durchsetzt sein und diese insofern nur zu einem bestimmten Anteil enthalten, wobei die Faserteile generell immer von den Blättern oder dem Stängel des HanfStrauches gebildet sein können. Hanffasern bzw. Hanfbestandteile haben allgemein den Vorteil einer entzündungshemmenden und heilungsfördernden Wirkung der Kontaktschicht .According to another preferred embodiment of the device according to the invention it is provided that the contact layer is formed by fiber parts of the hemp shrub. The contact layer may alternatively be made of a conventional material such as wool or fleece and thereby be interspersed only with certain fiber parts of hemp shrubs and thus contain only a certain proportion, the fiber parts always always from the leaves or the Stems of hemp shrub may be formed. Hemp fibers or hemp components generally have the advantage of an anti-inflammatory and healing-promoting effect of the contact layer.

Die Kontaktschicht ist für einen ersten Anwendungszweck zum Abdecken von Hautpartien hydrophil ausgebildet ist, um an einer verletzten Hautstelle austretende Körperflüssigkeit aufzunehmen. Für einen zweiten Anwendungszweck zum Einzutragen von Substanzen in den menschlichen Körper ist die Kontaktschicht vorzugsweise als Reservoir für an vorgesehene Hautstellen abzugebende epidermispermeable medizinisch wirksame Substanzen vorgesehen.The contact layer is designed to be hydrophilic for a first application for covering areas of skin in order to absorb bodily fluid escaping from an injured skin area. For a second application for introducing substances into the human body, the contact layer is preferably provided as a reservoir for epidermis-permeable medically active substances to be delivered to intended skin sites.

Gemäß wichtiger bevorzugter Ausführungsformen der erfindungsgemäßen Vorrichtung ist vorgesehen, dass das Reservoir beispielsweise einen Nikotin-Ersatzstoff, Insulin, ein gegen Asthma wirksamen Kortison oder eine das vegetative Nervensystem sedierende Substanz zur Bekämpfung von Reisekrankheiten enthält.According to important preferred embodiments of the device according to the invention, it is provided that the reservoir contains, for example, a nicotine substitute, insulin, an asthma-effective cortisone or a substance that controls the vegetative nervous system for the control of travel diseases.

Die erfindungsgemäße Vorrichtung wird im folgenden anhand bevorzugter Ausführungsformen erläutert, die in den Figuren der Zeichnung dargestellt sind. Darin zeigen:The device according to the invention is explained below with reference to preferred embodiments, which are illustrated in the figures of the drawing. Show:

Fig. 1 eine erste bevorzugte Ausführungsform der erfindungsgemäßen Vorrichtung in einer Ansicht von oben;Fig. 1 shows a first preferred embodiment of the device according to the invention in a view from above;

Fig. 2 die in Figur 1 dargestellte bevorzugte Ausführungsform der erfindungsgemäßen Vorrichtung in einer Querschnittsansicht; Fig. 3 eine andere bevorzugte Ausführungsform der erfindungsgemäßen Vorrichtung in einer Ansicht von oben;FIG. 2 shows the preferred embodiment of the device according to the invention shown in FIG. 1 in a cross-sectional view; FIG. Fig. 3 shows another preferred embodiment of the device according to the invention in a view from above;

Fig. 4 eine weitere bevorzugte Ausführungsform der erfindungsgemäßen Vorrichtung in einer Ansicht von oben;4 shows a further preferred embodiment of the device according to the invention in a view from above;

Fig. 5 eine weitere bevorzugte Ausführungsform der erfindungsgemäßen Vorrichtung in einer Ansicht von oben.Fig. 5 shows a further preferred embodiment of the device according to the invention in a view from above.

Fig. 6 eine weitere bevorzugte Ausführungsform der erfindungsgemäßen Vorrichtung in einer Ansicht von oben.Fig. 6 shows a further preferred embodiment of the device according to the invention in a view from above.

Die in den Figuren 1 bis 6 dargestellten erfindungsgemäßen Pflaster-Vorrichtungen 100 zum Abdecken ausgewählter Stellen der menschlichen Haut enthalten eine Trägerschicht 110 mit einer Oberfläche 111 und einer Unterfläche 112, wobei die Oberfläche 111 mit einer Schutzschicht versehen ist, und wobei mindestens teilweise im Bereich der Unterfläche 112 eine Kontaktschicht 120 vorgesehen ist, deren Unterseite mit einer ausgewählten Hautstelle in Kontakt tritt. Die Schutzschicht weist dabei erfindungswesentlich eine Opazität mit einem Wert größer als 0,55 auf. Bei den in den Figuren dargestellten Ausführungsformen ist der Wert der Opazität im Bereich zwischen 0,6 und 0,9 bemessen, wobei die jeweilige Opazität durch eine entsprechende Schattierung der Farbe Braun erzeugt ist.The plaster devices 100 according to the invention for covering selected areas of the human skin shown in FIGS. 1 to 6 comprise a carrier layer 110 having a surface 111 and a bottom surface 112, the surface 111 being provided with a protective layer, and being at least partially in the region of Bottom surface 112, a contact layer 120 is provided, the underside of which contacts a selected skin site. The protective layer has an essential to the invention an opacity with a value greater than 0.55. In the embodiments shown in the figures, the value of the opacity is in the range between 0.6 and 0.9, the respective opacity being produced by a corresponding shade of the color brown.

Die Kontaktschicht 120 der dargestellten erfindungsgemäßenThe contact layer 120 of the illustrated invention

Pflaster-Vorrichtungen 100 ist vollständig von Faserteilen des HanfStrauches gebildet, wobei die Faserteile von denPlaster devices 100 are formed entirely of fiber parts of the hemp shrub, the fiber parts of which

Blättern und dem Stängel des HanfStrauches gebildet sind. Die Kontaktschicht 120 ist saugfähig hydrophil ausgebildet, um an verletzten Hautstellen austretende Körperflüssigkeiten aufzunehmen.Leaves and stems of hemp shrub are formed. The contact layer 120 is hydrophilically absorbent to absorb bodily fluids leaking from injured skin.

Die oben erläuterten Ausführungsbeispiele der Erfindung dienen lediglich dem Zweck eines besseren Verständnisses der durch die Ansprüche definierten erfindungsgemäßen Lehre, die als solche durch die Ausführungsbeispiele nicht eingeschränkt ist. The above-described embodiments of the invention are only for the purpose of better understanding of the teaching defined by the claims according to the invention, which is not limited as such by the embodiments.

Claims

PatentansprücheClaims 1. Pflaster-Vorrichtung (100) zum Abdecken ausgewählter Stellen der menschlichen Haut, mit einer Trägerschicht (110) mit einer Oberfläche (111) und einer Unterfläche1. plaster device (100) for covering selected areas of the human skin, with a carrier layer (110) with a surface (111) and a lower surface (112), wobei die Oberfläche (111) mit einer Schutzschicht versehen ist, und mindestens teilweise im Bereich der(112), the surface (111) being provided with a protective layer, and at least partially in the region of the Unterfläche (112) eine Kontaktschicht (120) vorgesehen ist, deren Unterseite mit einer ausgewählten Hautstelle in Kontakt tritt, dadurch gekennzeichnet, dass dieLower surface (112) is provided a contact layer (120), the underside of which comes into contact with a selected skin site, characterized in that Schutzschicht eine Opazität mit einem Wert größer 0,55 aufweist .Protective layer has an opacity with a value greater than 0.55. 2. Vorrichtung nach Anspruch 1, dadurch gekennzeichnet, dass der Wert der Opazität im Bereich auf zwischen 0,6 und2. Device according to claim 1, characterized in that the value of the opacity in the range between 0.6 and 0,9 bemessen ist.0.9 is dimensioned. 3. Vorrichtung nach Anspruch 2, dadurch gekennzeichnet, dass der Wert der Opazität im Bereich auf zwischen 0,65 und 0,85 bemessen ist.3. Device according to claim 2, characterized in that the value of the opacity is dimensioned in the range between 0.65 and 0.85. 4. Vorrichtung nach Anspruch 3, dadurch gekennzeichnet, dass der Wert der Opazität im Bereich auf zwischen 0,65 und 0,8 bemessen ist.4. The device according to claim 3, characterized in that the value of the opacity is dimensioned in the range between 0.65 and 0.8. 5. Vorrichtung nach Anspruch 3, dadurch gekennzeichnet, dass der Wert der Opazität im Bereich auf zwischen 0,7 und 0,85 bemessen ist.5. The device according to claim 3, characterized in that the value of the opacity is dimensioned in the range between 0.7 and 0.85. 6. Vorrichtung nach Anspruch 2, dadurch gekennzeichnet, dass der Wert der Opazität im Bereich auf zwischen 0,75 und 0,9 bemessen ist. 6. The device according to claim 2, characterized in that the value of the opacity is dimensioned in the range between 0.75 and 0.9. 7. Vorrichtung nach einem oder mehr der Ansprüche 1 bis β, dadurch gekennzeichnet, dass die jeweilige Opazität durch eine entsprechende Schattierung der Farbe Braun erzeugt ist.7. The device according to one or more of claims 1 to β, characterized in that the respective opacity is generated by a corresponding shading of the color brown. 8. Vorrichtung nach einem oder mehr der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass die Kontaktschicht (120) von Faserteilen des HanfStrauches gebildet ist.8. The device according to one or more of claims 1 to 7, characterized in that the contact layer (120) is formed by fiber parts of the hemp shrub. I 9. Vorrichtung nach einem oder mehr der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass die Kontaktschicht (120) Faserteile des HanfStrauches enthält.I 9. Device according to one or more of claims 1 to 7, characterized in that the contact layer (120) contains fiber parts of the hemp shrub. 10. Vorrichtung nach einem der Ansprüche 8 oder 9, dadurch gekennzeichnet, dass die Faserteile von den Blättern oder dem Stängel des HanfStrauches gebildet sind.10. Device according to one of claims 8 or 9, characterized in that the fiber parts are formed by the leaves or the stem of the hemp shrub. 11. Vorrichtung nach einem oder mehr der Ansprüche 1 bis 10, dadurch gekennzeichnet, dass die Kontaktschicht (120) saugfähig hydrophil ausgebildet ist, um an verletzten Hautstellen austretende Körperflüssigkeiten aufzunehmen.11. The device according to one or more of claims 1 to 10, characterized in that the contact layer (120) is made absorbent hydrophilic in order to absorb body fluids escaping from injured skin areas. 12. Vorrichtung nach einem oder mehr der Ansprüche 1 bis 10, dadurch gekennzeichnet, dass die Kontaktschicht (120) als Reservoir für an vorgesehene Hautstellen abzugebende epidermispermeable medizinisch wirksame Substanzen vorgesehen ist.12. The device according to one or more of claims 1 to 10, characterized in that the contact layer (120) is provided as a reservoir for epidermispermeable medicinally active substances to be delivered to the intended skin sites. 13. Vorrichtung nach Ansprüche 12, dadurch gekennzeichnet, dass das Reservoir einen Nikotin-Ersatzstoff enthält.13. The device according to claims 12, characterized in that the reservoir contains a nicotine substitute. 14. Vorrichtung nach Ansprüche 12, dadurch gekennzeichnet, dass das Reservoir Insulin enthält. 14. The device according to claim 12, characterized in that the reservoir contains insulin. 15. Vorrichtung nach Ansprüche 12, dadurch gekennzeichnet, dass das Reservoir ein gegen Asthma wirksamen Kortison enthält.15. The device according to claim 12, characterized in that the reservoir contains a cortisone effective against asthma. 5 16. Vorrichtung nach Ansprüche 12, dadurch gekennzeichnet, dass das Reservoir eine das vegetative Nervensystem sedierende Substanz zur Bekämpfung von Reisekrankheiten enthält .16. The device according to claims 12, characterized in that the reservoir contains a substance that sedates the vegetative nervous system to combat travel sickness. ]_0 * *** *] _0 * *** * 1515 2020th 2525th 30 30th
PCT/DE2003/001786 2003-06-02 2003-06-02 Dressing Ceased WO2004110323A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03817241A EP1680058A1 (en) 2003-06-02 2003-06-02 Dressing
PCT/DE2003/001786 WO2004110323A1 (en) 2003-06-02 2003-06-02 Dressing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DE2003/001786 WO2004110323A1 (en) 2003-06-02 2003-06-02 Dressing

Publications (1)

Publication Number Publication Date
WO2004110323A1 true WO2004110323A1 (en) 2004-12-23

Family

ID=33546406

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2003/001786 Ceased WO2004110323A1 (en) 2003-06-02 2003-06-02 Dressing

Country Status (2)

Country Link
EP (1) EP1680058A1 (en)
WO (1) WO2004110323A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027859A3 (en) * 2003-09-23 2005-05-12 Reed Gamble Patch

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB439085A (en) * 1935-02-06 1935-11-28 Ernst Gelinsky Improvements in or relating to dressings for wounds and the like
US2905174A (en) * 1957-09-27 1959-09-22 Johnson & Johnson Adhesive bandage
US3156242A (en) * 1962-03-29 1964-11-10 Johnson & Johnson Flexible absorbent sheet
GB1071191A (en) * 1963-12-24 1967-06-07 Johnson & Johnson Absorbent non-woven fibrous product
US4161176A (en) * 1977-04-05 1979-07-17 Frederick Earl Harris, II Color adaptable bandage
DE3513526A1 (en) * 1985-04-16 1986-10-16 Hoechst Ag, 6230 Frankfurt Anti-cohesively treated plastic film, process for the production of the film and the use thereof
WO1993017647A1 (en) * 1992-03-05 1993-09-16 Avery Dennison Corporation Emulsion pressure-sensitive adhesive polymers in bandage and medical tape constructions
EP0484543B1 (en) * 1990-04-24 1995-12-13 Teijin Limited Plaster
DE29517506U1 (en) * 1995-11-04 1996-06-05 Pirro, Michael, 66424 Homburg Self-adhesive sun protection plasters
US5631078A (en) * 1995-10-30 1997-05-20 Eastman Chemical Company Films made from paper containing cellulose ester fiber
DE29716589U1 (en) * 1997-09-16 1997-11-27 Evers, Henning, 23821 Rohlstorf band Aid
DE19631848A1 (en) * 1996-08-07 1998-02-12 Wess Transporte Template for forming sun=tan motif on skin with UV light
WO2001007096A1 (en) * 1999-07-28 2001-02-01 Dardai Zoltan Plaster for introducing pharmaceutical compositions in living organisms
US6224900B1 (en) * 1986-08-28 2001-05-01 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Sealing bag for a transdermal therapeutic system
WO2001091681A1 (en) * 2000-06-01 2001-12-06 Ucb S.A. Wound dressing
US6471988B1 (en) * 1998-06-26 2002-10-29 Medeikonos Ab Device for protection against the sun and application of substance to the skin

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB439085A (en) * 1935-02-06 1935-11-28 Ernst Gelinsky Improvements in or relating to dressings for wounds and the like
US2905174A (en) * 1957-09-27 1959-09-22 Johnson & Johnson Adhesive bandage
US3156242A (en) * 1962-03-29 1964-11-10 Johnson & Johnson Flexible absorbent sheet
GB1071191A (en) * 1963-12-24 1967-06-07 Johnson & Johnson Absorbent non-woven fibrous product
US4161176A (en) * 1977-04-05 1979-07-17 Frederick Earl Harris, II Color adaptable bandage
DE3513526A1 (en) * 1985-04-16 1986-10-16 Hoechst Ag, 6230 Frankfurt Anti-cohesively treated plastic film, process for the production of the film and the use thereof
US6224900B1 (en) * 1986-08-28 2001-05-01 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Sealing bag for a transdermal therapeutic system
EP0484543B1 (en) * 1990-04-24 1995-12-13 Teijin Limited Plaster
WO1993017647A1 (en) * 1992-03-05 1993-09-16 Avery Dennison Corporation Emulsion pressure-sensitive adhesive polymers in bandage and medical tape constructions
US5631078A (en) * 1995-10-30 1997-05-20 Eastman Chemical Company Films made from paper containing cellulose ester fiber
DE29517506U1 (en) * 1995-11-04 1996-06-05 Pirro, Michael, 66424 Homburg Self-adhesive sun protection plasters
DE19631848A1 (en) * 1996-08-07 1998-02-12 Wess Transporte Template for forming sun=tan motif on skin with UV light
DE29716589U1 (en) * 1997-09-16 1997-11-27 Evers, Henning, 23821 Rohlstorf band Aid
US6471988B1 (en) * 1998-06-26 2002-10-29 Medeikonos Ab Device for protection against the sun and application of substance to the skin
WO2001007096A1 (en) * 1999-07-28 2001-02-01 Dardai Zoltan Plaster for introducing pharmaceutical compositions in living organisms
WO2001091681A1 (en) * 2000-06-01 2001-12-06 Ucb S.A. Wound dressing

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027859A3 (en) * 2003-09-23 2005-05-12 Reed Gamble Patch

Also Published As

Publication number Publication date
EP1680058A1 (en) 2006-07-19

Similar Documents

Publication Publication Date Title
EP3069578B1 (en) Device for treating a body surface of a living body
DE10063634B4 (en) Device and method for introducing an active substance into the skin
EP0107051A2 (en) Wound covering for bandages or compresses
DE2420345B2 (en) Skin test coverage
EP2257254B1 (en) Patch
DE102005043929B3 (en) Device to put a substance into the skin comprises parallel rollers with protruding needles situated such that their outer cirumferences do not overlap, enabling safe and even application of substance
EP1680058A1 (en) Dressing
DE3643153C2 (en)
DE20308636U1 (en) Transdermal plaster, useful for covering selected areas of human skin, comprises a carrier layer whose top surface is provided with a protective layer with a specified minimum opacity
DE4336631C2 (en) Device for irradiating the human body
DE102020134781B4 (en) Improved Patch
DE102008035848A1 (en) Patch, useful e.g. for attaching to skin for medical, cosmetic and/or orthopedic purposes, and to treat capsule inflammations, comprises a film comprising a carrier material provided with a therapeutically effective coating on both sides
DE10158424C2 (en) Device for treating insect bites
DE10345665A1 (en) Plaster for external wounds has carrier layer forming frame surrounding window closed by wound covering made of silk
EP3717052A1 (en) Cannula fixation plaster
DE202020107505U1 (en) Improved patch
DE1489693B1 (en) Protective device for the relief of pain caused by static electricity in a wound or on the human epidermis
DE2817809C2 (en) Earplugs and process for their manufacture
DE3233258A1 (en) Method for determining the efficacy of a composition on the skin of a person, in particular for determining the sunscreen factor of a sunscreen composition
Naegeli Das Problem der Personen-und Kontextrelativität
DE202005021421U1 (en) Device for intravascular laser blood irradiation
DE7817327U1 (en) Test patch strips
DE202021101768U1 (en) Textile garment and face mask
DE2214102A1 (en) DEVICE FOR CARE, REVITALIZATION AND / OR THERAPY OF THE SKIN
DE202021001931U1 (en) Hand-held device for treating human skin with a direct plasma jet

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003817241

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003817241

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP